Michael A. Sherman - 17 Jan 2023 Form 4 Insider Report for CHIMERIX INC

Role: Chief Executive Officer, Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 17 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 19 Jan 2023, 20:46:24 UTC
Previous filing: 27 Jul 2022
Next filing: 16 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Award	$0	+92,950	+71%	$0.000000	222,995	17 Jan 2023	Direct	F1, F2
holding	CMRX	Common Stock						102,995	17 Jan 2023	By Sherman Investors LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+557,050		$0.000000	557,050	17 Jan 2023	Common Stock	557,050	$1.97	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 23,237 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 23,239 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2	Includes 4,681 shares acquired under the Issuer's Employee Stock Purchase Plan on September 9, 2022.
F3	1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.